期刊文献+

多时段血糖控制对糖尿病肾病转归的影响研究 被引量:2

Analysis of 2-year follow up on diabetic nephropathy in patients under test and control of blood glucose more than 6 time in one day.
下载PDF
导出
摘要 目的探讨多时段血糖控制对糖尿病肾病治疗的作用。方法对76例确诊2型糖尿病病人进行每月多时段血糖监测及根据结果进行降糖药物调整使血糖稳定,观察2年;对照组为35例根据空腹及早餐后血糖监测调整降糖药物。定期检查所有病人尿蛋白、血糖、血压及HbA1c等。结果两组糖尿病肾病发生或发展情况经过秩和检验P值小于0.05,两组间的处理结果的差别有统计学意义,说明多时段血糖控制组其肾病改善及稳定的阳性率高于对照组,而发生肾病加重的阳性率低于对照组。结论:多时段血糖控制可延缓2型糖尿病肾病的发生并对肾病有改善作用。 objective To study the onset and development of diabetic nephropathy undergoing 2 years. When treated with more than 6 points of blood glucose test and control in one day.Method Diagnosised 76 instances with type 2 diabetes(as experimental group) were treated with more than 6 points of blood glucose test and control in one day monthly,but diagnosised 35 cases as control group treated with 2 points of blood glucose test and control in one day morning monthly. All patients were observed for 2 years,and regularly examined urineary protein,blood glucose, blood pressure and HbA1c. Result The numbers of onset and development of diabetic nephropathy in experimental group were higher than those in control group. Conclusion The more than 6 points blood glucose test and control will delay the onset and development of complication as diabetic nephropathy in type 2 diabetes.
出处 《广西医学》 CAS 2005年第11期1733-1735,共3页 Guangxi Medical Journal
基金 广西壮族自治区自然科学基金资助项目(合同号:2002019)
关键词 糖尿病肾病 多时段血糖 监测与控制 Diabetic nephropathy The more point of blood glucose Test and control in one day
  • 相关文献

参考文献8

  • 1贾伟平.血糖控制达标是预防糖尿病并发症的关键[J].上海医学,2005,28(1):1-3. 被引量:46
  • 2Nicholas L, Robert Loon,MB,BCh,et al. Diabetec kidney disease:preventing dialysis and transplantation[J]. Clinical Diabetes, 2003,21(1): 55 ~62.
  • 3Kalia K, Sharma S, Mistry K. None-enzymatic glycosylation of immunoglobulins in diabetic nephropathy[J]. Clin Chim Acta,2004,347(1 ~ 2):169~ 176.
  • 4Arzu Ergen H, Hatemi H, Agachan B, et al. Angiotensin-I converting enzyme gene polymorphiim in Turkish type 2 diabetic patients[J]. Exp MolMed,2004,36(4) :345 ~ 350.
  • 5Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long term complications in insulin-dependent diabetes mellitus[J]. N Engl JMed, 1993,329(14) :977 ~ 986.
  • 6UK Prospective Diabetes Study Group. Intensive blood glucose control with sulphony-ureas or insuli compared with conventional treatment and risk of complications in patient with type 2 diabetes(UKPDS33)[J]. Lancet,1998,352(9 131) :837 ~ 853.
  • 7Strtton IM, Adler Al, Neil HA, et al. Association of glycaemia macrovascullar and microvascular complications of type 2 diabetes(UKPDS35): prospective obvervational study[J]. B M J,2000,321(4) :405 ~ 412.
  • 8American Diabetes Association. Implications of the diabetes control and complications trial[J]. Diabetes Care, 2000, 23(suppl 1): 24.

二级参考文献12

  • 1贾伟平,于浩泳,项坤三.胰岛素脉冲样分泌的意义及临床应用[J].中华内分泌代谢杂志,2004,20(4). 被引量:6
  • 2潘长玉,田慧,刘国良,李秀钧,傅祖植,陈家伟,暨亚洲糖尿病管理中国协作组.中国城市中心医院糖尿病健康管理调查[J].中华内分泌代谢杂志,2004,20(5):420-424. 被引量:193
  • 3姜素英,左玉华,张和平,徐文,刘芳,贾伟平.社区糖尿病治疗达标现状分析[J].上海医学,2005,28(1):30-32. 被引量:31
  • 4卫生部疾病控制司 中华医学会糖尿病学分会.中国糖尿病防治指南[Z].,2003.4-6.
  • 5DCCT Group. The effect of intensive treatment of diabetes on the development and progression of long term complications in IDDM. N Engl J Med, 1993, 329: 977-987.
  • 6The diabetes control and complications trial/epidemiology of diabetes interventions and complications research group. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. N Engl J Med, 2000,342:381- 389.
  • 7Nathan DM, l.achin J,Cleary P, et al. Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus. N Engl J Med, 2003,348: 2294-2303.
  • 8UKPAD Group. Intensive blood glucose control with sulphonylureas or insulin compared with conventiional treatment and risk of complications in patients with type 2 diabetes(UKPDS33). Lancet, 1998, 352:837-853.
  • 9Stevens RJ, Coleman RI., Adler AI, et al. Risk factors for myocardial infarction case falality and stroke case fatality in type 2 diabetes. Diabetes Care, 2004, 27: 201-207.
  • 10Tominaga M, Eguchi H, Manaka H, et al. Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose: The Funagata Diabetes Study. Diabetes Care, 1999, 22: 920-924.

共引文献45

同被引文献7

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部